tiprankstipranks
Trending News
More News >
Merck & Company (DE:6MK)
XETRA:6MK

Compare Merck & Company (6MK) vs. Competitors

Compare
68 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Merck & Company
€103.20
$249.16B
15.72
20.42%
12 Buy
7 Hold
0 Sell
Moderate Buy
Gilead Sciences
$146.23
$181.42B
22.65
49.89%
14 Buy
2 Hold
0 Sell
Strong Buy
Novartis
$152.91
$290.69B
21.09
40.20%
1 Buy
4 Hold
1 Sell
Hold
Pfizer
$25.77
$152.26B
19.69
0.19%
5 Buy
12 Hold
0 Sell
Moderate Buy
Sanofi
$48.08
$116.85B
13.31
-11.23%
2 Buy
3 Hold
0 Sell
Moderate Buy
AstraZeneca
13796.00p
£213.91B
29.71
25.65%
13 Buy
1 Hold
1 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:6MK
Merck & Company
103.20
20.88
25.37%
GILD
Gilead Sciences
149.37
54.00
56.62%
NVS
Novartis
153.95
50.12
48.27%
PFE
Pfizer
26.49
2.41
10.00%
SNY
Sanofi
47.49
-3.75
-7.31%
GB:AZN
AstraZeneca
13,980.00
2,443.78
21.18%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts